United States: Celltrion Announces Commercial Availability Of ZYMFENTRA™ (Infliximab-dyyb) - Goodwin Procter LLP

Credit: Mondaq- Published on March 26, 2024
Celltrion USA announced on March 18, 2024, the availability of ZYMFENTRA™ (infliximab-dyyb), a subcutaneous (SC) formulation of infliximab.
👓 View full article:  

You are here

› Legal › United States: Celltrion Announces Commercial Availability Of ZYMFENTRA™ (Infliximab-dyyb) - Goodwin Procter LLP

You might like

© 2024 newsR Ltd.
All Rights Reserved.

Contact us





Video

🔝 Scroll back up to the top

⌂ Home Page

Desktop version of this page:
🖥️ United States: Celltrion Announces Commercial Availability Of ZYMFENTRA™ (Infliximab-dyyb) - Goodwin Procter LLP